Title:
経口又は非経口抗糖尿病薬による治療にもかかわらず不十分な血糖調節の患者の糖尿病の治療
Document Type and Number:
Japanese Patent JP6811203
Kind Code:
B2
Abstract:
The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients with insufficient glycemic control despite a therapy with an oral and/or a non-oral antidiabetic drug.
Inventors:
Grefe-Modieva Urrique
Klein Thomas
Marc michael
Verrehans Jürgen
Klein Thomas
Marc michael
Verrehans Jürgen
Application Number:
JP2018083792A
Publication Date:
January 13, 2021
Filing Date:
April 25, 2018
Export Citation:
Assignee:
Boehringer Ingelheim International GmbH
International Classes:
A61K31/522; A61K31/155; A61K38/28; A61P3/10; A61P43/00
Other References:
WANG Y,BI-1356. DIPEPTIDYL-PEPTIDASE IV INHIBITOR, ANTIDIABETIC AGENT,DRUGS OF THE FUTURE,ES,PROUS SCIENCE,2008年 6月 1日,V33 N6,P473-477
PEI Z,FROM THE BENCH TO THE BEDSIDE: DIPEPTIDYL PEPTIDASE IV INHIBITORS, A NEW CLASS 以下備考,CURRENT OPINION IN DRUG DISCOVERY AND DEVELOPMENT,英国,2008年 7月 1日,V11 N4,P512-532,OF ORAL ANTIHYPERGLYCEMIC AGENTS
HERMANSEN,K. et al,Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 di,Diabetes, obesity & metabolism,2007年,Vol.9, No.5,p.733-745
Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled,Diabetes, Obesity and Metabolism,2008年 2月,Vol.10, No.11,p.1047-1056
PEI Z,FROM THE BENCH TO THE BEDSIDE: DIPEPTIDYL PEPTIDASE IV INHIBITORS, A NEW CLASS 以下備考,CURRENT OPINION IN DRUG DISCOVERY AND DEVELOPMENT,英国,2008年 7月 1日,V11 N4,P512-532,OF ORAL ANTIHYPERGLYCEMIC AGENTS
HERMANSEN,K. et al,Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 di,Diabetes, obesity & metabolism,2007年,Vol.9, No.5,p.733-745
Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled,Diabetes, Obesity and Metabolism,2008年 2月,Vol.10, No.11,p.1047-1056
Attorney, Agent or Firm:
Shinichiro Tanaka
Hiroyuki Suda
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Yasushi Sasaki
Hiroyuki Suda
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Yasushi Sasaki